Your session is about to expire
← Back to Search
Patient Feedback Surveys for Breast Cancer
N/A
Recruiting
Led By Sarah Tevis
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult (18 years of age or more)
Female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
Study Summary
This trial is measuring how well a new way of reporting cancer treatment results to patients works.
Who is the study for?
This trial is for adult women (18 years or older) who have been diagnosed with breast cancer and are capable of completing surveys on their own. It's not suitable for anyone under 18, men, or patients unable to fill out surveys independently.Check my eligibility
What is being tested?
The study focuses on measuring Patient Reported Outcome Measures (PROMs) in breast cancer patients. Feedback from these PROMs will be shared with both the patients and their healthcare providers to assess how it affects patient engagement, service use, and satisfaction with communication.See study design
What are the potential side effects?
Since this trial involves completing surveys rather than testing a medical intervention like a drug or therapy, there are no direct side effects associated with participating in this research.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am female.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
BREAST Q patient satisfaction with breast surgeon domain
Secondary outcome measures
BREAST Q Patient reported outcome measure survey domains including: Satisfaction with breasts, psychosocial well being, physical well being, sexual well being, and effects of radiation domains.
Currently unmeasured patient reported outcomes using open ended questions
Healthcare utilization including the use of social work services, psycho-oncology services, oncology fitness service, nutrition service, and urgent/emergent services including visits to urgent care or the emergency room.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental GroupExperimental Treatment1 Intervention
Patients will receive the results from the PROM survey in graphical form each time they complete a survey.
Group II: Normative ControlActive Control1 Intervention
These patients will complete the PROM surveys, but will not be presented with the results of the survey.
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,748 Previous Clinical Trials
2,163,596 Total Patients Enrolled
28 Trials studying Breast Cancer
6,499 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,708 Previous Clinical Trials
40,932,359 Total Patients Enrolled
941 Trials studying Breast Cancer
1,543,596 Patients Enrolled for Breast Cancer
Sarah TevisPrincipal InvestigatorUniversity of Colorado, Denver
4 Previous Clinical Trials
475 Total Patients Enrolled
4 Trials studying Breast Cancer
475 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I am 18 years old or older.I have breast cancer.I am female.I am male.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental Group
- Group 2: Normative Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To what extent are participants engaging in this experiment?
"Affirmative, the clinicaltrials.gov database reveals that this research is actively enlisting participants. Originally posted on October 30th 2019, this trial seeks 370 individuals from 3 distinct medical centers for enrollment."
Answered by AI
Are there any current openings to join this experiment?
"Affirmative. The clinical trial information found on clinicaltrials.gov verifies that the study is currently recruiting volunteers, having been initially posted on October 30th 2019 and last modified August 22nd 2022. A total of 370 participants are needed at 3 different sites for this experiment to be successful."
Answered by AI
Share this study with friends
Copy Link
Messenger